Get the app
Tom Foltynie
Professor at University College London, leading researcher in Parkinson's disease clinical trials and disease-modifying treatments. Expert on GLP-1 agonists.
Best podcasts with Tom Foltynie
Ranked by the Snipd community
Mar 31, 2025
• 0sec
Special Issue: GLP-1 agonists in Parkinson’s disease: New evidence, new questions?
chevron_right
In this engaging discussion, Professor Tom Foltynie from University College London delves into a recent phase 3 clinical trial of exenatide for Parkinson’s disease. Despite disappointment in the results, he examines potential reasons behind the discrepancies from earlier studies. Foltynie explores how GLP-1 agonists could still play a vital role in early-stage Parkinson’s treatment and details advancements in clinical trial designs, which may pave the way for more effective therapies. Tune in for insights into the future of Parkinson’s research!
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
